Select region

Press release Gothenburg, 2016-06-30

Getinge Group announces date of Interim Report January-June 2016 and conference call

Getinge will issue its Interim Report for January-June 2016 on Thursday July 14th at 08:00 CET, followed by a conference call at 10:00 CET, hosted by Alex Myers, President & CEO, and Pernille Fabricius, CFO.

We invite fund managers, analysts and the media to participate in the conference call. Please see below details to join the conference:

Swedish dial in number: +46 (0)8 5065 3937
UK dial in number: +44 (0)20 3427 1907
US dial in number: +1 212 444 0896
Participant passcode: 4449409

09:45 Call in to the conference
10:00 Review of the Q1 report
10:20 Q&A
11:00 End of conference

Two hours after the end of the conference call, a recorded version of the conference can be accessed for 5 working days on the following number:
Sweden: +46 (0)8 5051 3897
UK: +44 (0)20 3427 0598
US: +1 347 366 9565
Code: 4449409

During the telephone conference a presentation will be held. To access the presentation, please use this link:

Alternatively enter the Live Meeting site and log into your meeting using the Meeting ID and Password below:
Live Meeting:
Your Name: (Enter your name)
Meeting ID: 4449409
Meeting Password: pw1111

For more information, please contact:
Kornelia Rasmussen, Executive Vice President Communications & Brand Management
Phone: +46 (0)10 335 5810

Getinge Group is a leading global provider of innovative solutions for operating rooms, intensive-care units, hospital wards, sterilization departments, elderly care and for life science companies and institutions. Getinge’s unique customer offering mirrors the hospital’s organization and value chain, and the solutions are used before, during and after the patients’ hospital stay. Based on first-hand experience and close partnerships, Getinge provides innovative healthcare solutions that improve every-day life for people, today and tomorrow.

The information is such that Getinge AB must disclose in accordance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act.